Nalidixic acid in children: Retrospective matched controlled study for cartilage toxicity U. B. SchaadJoanna Wedgwood-Krucko Originalia Pages: 165 - 168
Streptococcus agalactiae (group B) endocarditis — A description of twelve cases and review of the literature B. E. ScullyH. C. NeuD. Spriggs Originalia Pages: 169 - 176
Septicemia and endocarditis, 1965–1980, in a Swedish university hospital for infectious diseases I. Julander Originalia Pages: 177 - 183
Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers G. W. WellingG. GroenD. van der Waaij Originalia Pages: 188 - 191
Pneumococcal antibody levels in patients with acute lung infiltrates A. LöwenbergH. J. SluiterL. Th. v. d. Weele Originalia Pages: 192 - 199
Streptococcus milleri subcutaneous abscesses in drug addicts F. MüllerA. von GraevenitzT. Ferber Letter To The Editor Pages: 201 - 201
Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate L. MaaßM. VerhoN. Klesel Addendum “Cefpirome (HR 810)” Pages: 202 - 206
Pharmacokinetics of cefpirome (HR 810), a new cephalosporin derivative administered intramuscularly and intravenously to healthy volunteers L. MaaßM. VerhoV. Malerczyk Addendum “Cefpirome (HR 810)” Pages: 207 - 210
Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivative L. MaaßM. VerhoN. Klesel Addendum “Cefpirome (HR 810)” Pages: 211 - 214
Renal tolerance of cefpirome (HR 810), a new cephalosporin antibiotic M. VerhoL. MaaßH. Grötsch Addendum “Cefpirome (HR 810)” Pages: 215 - 219